¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 Çѱ¹¸Á¸·ÇÐȸ ÇÏ°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-06-22

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 Çѱ¹¸Á¸·ÇÐȸ ÇÏ°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-06-22
±³À°ÀÏÀÚ : 2024-06-22
±³À°Àå¼Ò : ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ4F

±³À°ÁÖÁ¦ : 2024 Çѱ¹¸Á¸·ÇÐȸ ÇÏ°èÇмú´ëȸ (2ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѾȰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Çѱ¹¸Á¸·ÇÐȸ

´ã´çÀÚ : ¹ÚÀ±Á¤
¿¬¶ôó : 02-471-6520

À̸ÞÀÏ : retina@retina.or.kr

±³À°Á¾·ù : ¾È°ú

Âü¼®¿¹»óÀÎ : 170¸í
Èñ¸ÁÆòÁ¡ : 1Á¡

Áö¿ª : ±¤ÁÖ±¤¿ª½Ã
±³À°½Ã°£ : 1 ½Ã°£ 36ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 09:00~09:08 (ÃÊ·Ï)Asian Subgroup Analysis of a Phase III Study Comparing SB15 with Reference Aflibercept (Eylea) in Neovascular Age-related Macular Degeneration ÀÌÁÖ¿ë(¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 09:08~09:16 (ÃÊ·Ï)Real-world incidence and risk factors of incident non-infectious uveitis in patients treated with Immune checkpoint inhibitors ±è¿ëÁØ(¿¬¼¼´ë)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 09:16~09:24 (ÃÊ·Ï)Progression of myopia and related structural changes in retina: school-based prospective cohort study ¹è°ÇÈ£(¼­¿ï´ë)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 09:24~09:32 (ÃÊ·Ï)Cost-effectiveness of the anti-vascular endothelial growth factor intravitreal injection and panretinal photocoagulation for patients with proliferative diabetic retinopathy in South Korea Áöµ¿Çö(°¡Å縯´ë)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 09:32~09:40 (ÃÊ·Ï)Case series of branch retinal vein occlusion secondary to rhegmatogenous retinal detachment and its surgical management ¹Ú¼ºÈÄ(ºÎ»ê´ë)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 09:40~09:48 (ÃÊ·Ï)Prevalence and Risk Factors of Age-related Macular Degeneration in South Korea: Korea National Health and Nutrition Examination Survey 2017-2020 ±èÀçÈÖ(±è¾È°úº´¿ø)

ÈÞ½Ä 06¿ù 22ÀÏ 09:48~09:55 ÈÞ½Ä -(-)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 09:55~10:03 (ÃÊ·Ï)Introducing New Retinal Vessel Analysis Software: SEoul Retinal Vessel Assessment Library (SERVAL) ¹Ú»óÁØ(¼­¿ï´ë)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 10:03~10:11 (ÃÊ·Ï)Multimodal deep learning-based prediction of treatment response in diabetic macular edema À±Á¦¹®(¼º±Õ°ü´ë)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 10:11~10:19 (ÃÊ·Ï)A novel fluorescent diagnostic agent targeting choroidal neovascularization Ãֽ¿ì(¼­¿ï´ë)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 10:19~10:27 (ÃÊ·Ï)Epiretinal Membrane: Exploring Correlations between Clinical and immunohistochemical Characteristics and Their Prognostic Implications ¾çÇö½Â(¼­¿ï½Å¼¼°è¾È°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 10:27~10:35 (ÃÊ·Ï)Changes in the outer nuclear layer and choroidal vascularity during the manifest and quiescent phases of acute central serous chorioretinopathy ¼­ÀÇÁ¾(ÃæºÏ´ë)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 10:35~10:43 (ÃÊ·Ï)Macular microvasculature asymmetry in high myopia patients with open-angle glaucoma À̹οì(°Ç¾ç´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 Çѱ¹¸Á¸·ÇÐȸ ÇÏ°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-06-22""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) Á¦7ȸ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ¾îÁö·³Áõ¼¾ÅÍ ¿¬¼ö°­Á : 2024-06-22
´ÙÀ½±Û ´ëÇÑÃé´ãµµÇÐȸ [¿Â¶óÀÎ] Pancreato-Biliary Summer School 2024 (PB-SS) : 2024-06-22
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21017 ´ë±¸ 2024 ´ëÇÑÀÀ±ÞÀÇÇÐȸ Ãá°èÇмú´ëȸ (1ÀÏÂ÷) : 2024-06-27 0 45 2024-06-18
21016 ºÎ»ê 2024 ±ÝÁ¤±¸ÀÇ»çȸ Çмú´ëȸ(¿¹¹æÁ¢Á¾, ÇʼöÀÇ·áÆÐÅ°Áö) : 2024-06-27 0 48 2024-06-18
21015 ¼­¿ï (¿Â¶óÀÎ) 2024³â Á¦1Â÷ ÇÑÀϺ´¿ø °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-27 0 90 2024-06-18
21014 °æ³² Çѱ¹¿©ÀÚÀÇ»çȸ °æ³²Áöȸ 6¿ù Çмú½ÉÆ÷Áö¾ö : 2024-06-27 0 52 2024-06-18
21013 ¿ï»ê Á¦50ȸ ´ëÇÑ¿Ü°úÇÐȸ ¿ï»êÁöȸ : 2024-06-26 0 90 2024-06-18
21012 °æ±â ÀÌõ½ÃÀÇ»çȸ ¿¬¼ö°­ÁÂ(Æó±â´É°Ë»çÀÇ Çؼ®, õ½ÄÀÇ Áø´Ü°ú Ä¡·á) : 2024-06-26 0 71 2024-06-18
21011 ºÎ»ê 2024 »ç»ó±¸ÀÇ»çȸ Àü¹Ý±â Çмú´ëȸ(¸¸¼º±âħ, ÀÇ·á±â°ü Àλç³ë¹«) : 2024-06-26 0 62 2024-06-18
21010 ¼­¿ï (¿Â¶óÀÎ) ¼Ò¾Æû¼Ò³â°ú Çù·ÂÀÇ»ç Áý´ãȸ(Àú½ÅÀå°ú ¼ºÀåÈ£¸£¸ó Ä¡·á, ½Å»ý¾ÆÁúȯ) : 2024-06-25 0 73 2024-06-18
21009 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾư¨¿°ÇÐȸ Á¦192Â÷ ¿ù·Ê¿¬¼ö°­Á : 2024-06-25 0 79 2024-06-18
21008 ºÎ»ê ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ºÎ»ê°æ³²Áöȸ Çмúȸ : 2024-06-25 0 77 2024-06-17
21007 °æ³² â¿ø½Ã ¼Ò¾Æû¼Ò³â°úÁöȸ ¿¬¼ö°­ÁÂ(¼Ò¾Æ ¼ÒÈ­±â Áúȯ) : 2024-06-25 0 102 2024-06-17
21006 Ãæ³² ´Ü±¹´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú °³¿øÀÇ Çмúȸ(±¸°­°ÇÁ¶Áõ) : 2024-06-25 0 53 2024-06-17
21005 ¼­¿ï (¿Â¶óÀÎ) 2024³â 6¿ù ¼Ò¾Æ½ÉÃÊÀ½ÆÄ Áý´ãȸ : 2024-06-24 0 47 2024-06-17
21004 °æ±â 2024³â ¼Ò¾Æ¼ö¸é¿¬±¸È¸ Á¦2Â÷ Áý´ãȸ(¿Â¶óÀÎ) : 2024-06-24 0 54 2024-06-17
21003 Ãæ³² ´Ü±¹´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú (¿Â¶óÀÎ) 29th Vestibular Function Test Workshop : 2024-06-23 0 22 2024-06-17
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷